TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
about
Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery.Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study.Population-based analysis of pathological correlates of dementia in the oldest old.Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction.Impact of multiple pathologies on the threshold for clinically overt dementia.Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.Applying fluid biomarkers to Alzheimer's disease.Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration.Neuropathological comorbidity associated with argyrophilic grain disease.Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.Person-specific contribution of neuropathologies to cognitive loss in old age.Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.The Past and the Future of Alzheimer's Disease Fluid Biomarkers.Pathomechanisms of TDP-43 in neurodegeneration.Molecular biomarkers of Alzheimer's disease: progress and prospects.Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology.Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study
P2860
Q34550595-BE3952F2-7778-41EC-8702-AFEA939D98ACQ36307408-AC032F25-2FD3-4300-8B52-D8ADC4FEA620Q36325404-2D185026-A1CF-47CF-8DA3-E6071F3AA978Q37681993-97DCC36D-79F3-4E61-862C-600735339D58Q38776050-D016B28E-2A95-4B37-B56B-522F45387E12Q38794960-D30E361B-3424-4590-BC30-10AAF4BE212FQ38915426-47A34CCA-A657-484E-8606-F2E5AE12C320Q39251035-5D463720-B950-4AF1-B5E4-FFED58888A88Q41548991-A3286CEA-381E-42EA-B280-0D2A8982267BQ46251905-3E3F6A55-052A-4E04-A622-CEB82E5AA624Q47268164-FACAE74D-E1B9-4C0F-AE06-0A63DF1789B7Q47319999-88CBD7CE-B86C-4921-B92E-6B391E58F052Q47769597-61499FE2-C904-408E-981A-F45890104C7CQ47833979-16CB1E3D-1B41-40A2-9F5B-B07DDD09D045Q49824057-1F260673-6FE6-4439-B78B-EC4712B535C6Q51264997-88AD3EC6-49D5-4509-B156-E78ABCD542FDQ52589491-2E89D68B-482A-4316-B95F-9A82ED08999DQ52644601-6EA22154-34CA-4D7F-9CFF-81CEF8DC14F9Q52730092-E9D9CDAA-D72E-4BB9-9C56-E8D47E44A948Q54946040-3051C899-F330-4ED7-AEDB-8180E45652BEQ55003043-C794E9B3-F8F2-48AC-A50B-5A33A198593EQ55365163-01F15498-44DE-440F-82E0-4266BF43AEFAQ57165224-5150E31F-108A-451D-B2CF-16B4BDF67B58
P2860
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
@en
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
@nl
type
label
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
@en
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
@nl
prefLabel
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
@en
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
@nl
P2093
P2860
P356
P1433
P1476
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
@en
P2093
Bryan D James
Julie A Schneider
Patricia A Boyle
Robert S Wilson
P2860
P356
10.1093/BRAIN/AWW224
P407
P577
2016-09-30T00:00:00Z